Organovo's fatty liver disease drug meets main goal in mid-stage study
15/04/2024 13:13
April 15 (Reuters) - Organovo Holdings ONVO.O said on Monday its experimental drug to treat a type of fatty liver disease helped significantly reduce liver fat in a mid-stage study. (Reporting by Mariam Sunny in Bengaluru) ((Mariam.ESunny@thomsonreuters.com;))